tiprankstipranks

Stephanie Okey Insider Profile

4 Followers
Stephanie Okey, Director at Albireo Pharma, holds ― shares in Albireo Pharma (Ticker: ALBO), holds 12.63K shares in Catalent (Ticker: CTLT), holds 9.40K shares in Crinetics Pharmaceuticals (Ticker: CRNX). Most recently, Stephanie Okey ― shares of Albireo Pharma on ― for an estimated value of ―.
tipranks
Stephanie Okey

Stephanie Okey
Albireo Pharma (ALBO)
Director

Ranked #62,533 out of 99,635 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

-10.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
44.87%
30.55%
24.58%
A breakdown of Stephanie Okey's holdings

Insider Roles

Catalent
(CTLT)
Director
Crinetics Pharmaceuticals
(CRNX)
Director
PTC Therapeutics
(PTCT)
Director
Roles that Stephanie Okey holds in companies

Most Profitable Insider Trade

Stock:
PTC Therapeutics
(PTCT)
Rating:Informative Sell
Date:Aug 11, 2022 - Aug 11, 2023
Return:+19.80%
The most profitable trade made by Stephanie Okey

Stephanie Okey's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ALBO
Albireo Pharma
PTC Therapeutics
Feb 16, 2024
Director
Uninformative Buy
$424.18K
Crinetics Pharmaceuticals
Jun 11, 2024
Director
Uninformative Buy
$527.25K
Catalent
Nov 01, 2024
Director
Uninformative Buy
$774.40K
List of latest transactions for each holding click on a transaction to see Stephanie Okey's performance on stock

Stephanie Okey insider profile FAQ

What is the percentage of profitable transactions made by Stephanie Okey?
The percentage of profitable transactions made by Stephanie Okey is 33%.
    What is the average return per transaction made by Stephanie Okey?
    The average return per transaction made by Stephanie Okey is -10.80%.
      What stocks does Stephanie Okey hold?
      Stephanie Okey holds: ALBO, PTCT, CRNX, CTLT stocks.
        What was Stephanie Okey’s latest transaction?
        Stephanie Okey latest transaction was an Uninformative Buy of ―.
          What was Stephanie Okey's most profitable transaction?
          Stephanie Okey’s most profitable transaction was an Informative Sell of PTCT stock on August 11, 2022. The return on the trade was 19.80%.
            What is Stephanie Okey's role in Albireo Pharma?
            Stephanie Okey's role in Albireo Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.